Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncosec Medical Incorporated (ONCSQ)
:ONCSQ
Holding ONCSQ?
Track your performance easily
ONCSQ Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume1.10K
Average Volume (3M)1.27K
Market Cap
$596.00
Enterprise ValueN/A
Total Cash (Recent Filing)$11.44M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-90.34
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,962,652
10 Day Avg. Volume393
30 Day Avg. Volume1,269
Standard Deviation17.64
R-Squared0.00257
Alpha3.36
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
2.12% Other Institutional Investors
97.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ONCSQ FAQ
What was Oncosec Medical Incorporated’s price range in the past 12 months?
Currently, no data Available
What is Oncosec Medical Incorporated’s market cap?
Oncosec Medical Incorporated’s market cap is $596.00.
When is Oncosec Medical Incorporated’s upcoming earnings report date?
Oncosec Medical Incorporated’s upcoming earnings report date is Mar 12, 2025 which is in 50 days.
How were Oncosec Medical Incorporated’s earnings last quarter?
Currently, no data Available
Is Oncosec Medical Incorporated overvalued?
According to Wall Street analysts Oncosec Medical Incorporated’s price is currently Overvalued.
Does Oncosec Medical Incorporated pay dividends?
Oncosec Medical Incorporated does not currently pay dividends.
What is Oncosec Medical Incorporated’s EPS estimate?
Oncosec Medical Incorporated’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncosec Medical Incorporated have?
Oncosec Medical Incorporated has 5,962,652 shares outstanding.
What happened to Oncosec Medical Incorporated’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oncosec Medical Incorporated?
Currently, no hedge funds are holding shares in ONCSQ
---
Company Description
Oncosec Medical Incorporated
OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.
---
---